You searched for "Simulation"

2563 results found

Intravitreal injections delivered by ophthalmic clinical nurse specialists

Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...

Could the sclera be key to glaucoma?

The glaucomas are a group of conditions characterised by optic neuropathy and associated visual field defects. Of these, chronic open-angle glaucoma (COAG) – diagnosed on the basis of progressive structural changes to the optic nerve head (ONH) and nerve fibre...

Overcoming sight impairment for the Race Across the World!

RNIB’s Tricia travels the world and takes her message that "sight loss doesn’t stop you doing anything" to BBC One.

Sight loss befriender offers 'life changing' support to Freda

Sight Scotland, Scotland’s largest sight loss organisation, is appealing for more volunteer befrienders to help battle loneliness and isolation.

Bus driver swap sessions hit 50

Sight loss charity RNIB Scotland are marking their 50th ‘Swap with Me’ event with trainee bus drivers across Scotland this week. The hands-on sessions help drivers better understand the experiences of blind and partially sighted passengers. The sessions involve RNIB...

Conference Report: KCL Ophthalmology Society Annual Conference 2025

King’s College London (KCL) Ophthalmology Society 2024/25 hosted the third Annual KCL Ophthalmology National Conference 2025, entitled ‘Advancements and the Future of Ophthalmology’ in London on 5 April 2025. Held at Guy’s Campus, the event drew a wide audience from...

DSEK – five year results

This UK based study examined long-term descemet stripping endothelial keratoplasty (DSEK) results, looking at graft survival and endothelial cell losses. Data on 210 grafts were included in analysis. Most frequent indication for DSEK was Fuch’s endothelial dystrophy (81.4%) and 46.3%...

Phaco-ECP vs. Phaco alone to treat glaucoma

This retrospective review compared combined phacoemulsification and endoscopic cyclophotocoagulation (phaco-ECP) to phaco alone in patients with mild to moderate glaucoma. Outcome measures included cumulative full and qualified success survival, postintervention IOP and ocular anti-hypertensive medication reduction. Full success was defined...

Fifteen-year results of phakic artisan IOL for hyperopia correction

This retrospective review of a cohort of 61 eyes from 32 patients offers long-term results for phakic Artisan (Ophtec BV) iris-fixated phakic IOL (IF-pIOL). The mean age at surgery was 41.6 years with a range of 25-59 years. Refractive outcomes...

Lag time between symptom onset and retinoblastoma treatment affects outcomes

This was a prospective cohort study of 692 treatment-naïve retinoblastoma (RB) patients from 10 countries followed up for 3 years from recruitment to evaluate the effect of lag time between diagnosis of RB and treatment. The mean lag time from...

Strengthening diabetic retinopathy services in Nigeria through DR-NET – from grass roots to national policy development

This is the third article in a series (see Part 1 and Part 2) reflecting on how shared learning via networks of UK and international eye health professionals is contributing to reducing unnecessary blindness in Nigeria. Earlier articles focused on...

Ambient scribes: The silent revolution

Clinical practice is in the midst of a profound digital transformation with a new wave of technology gaining increasing prominence: ambient scribes. These AI-powered tools streamline documentation by converting doctor–patient conversations into structured clinical notes in near real time. Healthcare...